Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

Cancer and heart disease, two leading causes of death worldwide, may be more connected than we previously thought, according ...

The findings provide insight into which patients may have favorable or inferior responses to immunotherapy for small cell ...

Biomarker-targeted adjuvant therapy improved survival in early-stage NSCLC, highlighting the importance of testing and ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, and Noetik, a leader in AI-driven spatial and multimodal biology, today announced a research collaboration to develop predictive ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Suresh S. Ramalingam, MD, FACP, FASCO, emphasizes the role of community oncologists in translating new advancements in lung cancer research into widespread patient benefit.

Cancer patients found to have specific gene mutations or other biomarkers are being matched to precision treatments not ...